Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026)

Tyra Biosciences' (TYRA) quarterly Capital Expenditures came in at $88000.0 in Q1 2026, up 104.65% on a QoQ basis from $43000.0 in Q4 2025.

Tyra Biosciences (TYRA) Capital Expenditures (2020 - 2026) Analysis & Trends

Tyra Biosciences (TYRA) has 7 years of Capital Expenditures data on file, last reported at $88000.0 in Q1 2026.

Quarterly Capital Expenditures changed N/A year-over-year to $88000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156000.0 (down 70.45% YoY) and the FY2025 annual result came in at $68000.0, down 89.76% from the prior year.
Capital Expenditures improved to $88000.0 in Q1 2026, from $43000.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $624000.0 in Q3 2024 to a low of -$210000.0 in Q2 2022.
A 5-year average of $106000.0 and a median of $45000.0 in 2025 frame the typical range for Capital Expenditures.
Annual changes were most pronounced in 2022 — Capital Expenditures plunged 418.18% — and 2023, when it surged 6800.0%.
Tracing TYRA's Capital Expenditures over 5 years: stood at -$9000.0 in 2022, then surged by 6800.0% to $603000.0 in 2023, then slumped by 99.0% to $6000.0 in 2024, then jumped by 616.67% to $43000.0 in 2025, then surged by 104.65% to $88000.0 in 2026.
The last three Capital Expenditures figures came in at $88000.0 (Q1 2026), $43000.0 (Q4 2025), and -$20000.0 (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	112.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	240.20 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.29 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	25.02 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	572,662.23
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	251.02 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	34.68 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	6.26 Mn
10	Tyra Biosciences	1.51 Bn	1.51 Bn	-	66,000.00

Download Data